Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
PetMed Express, Inc. operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It sells its products through its Internet website and mobile app, and direct mail/print through catalogs, brochures, and postcards.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $303.6M | $272.3M | $247.6M | $274.1M | $227.0M | $179.0M |
| Gross profit | $84.3M | $76.9M | $76.5M | $84.8M | $69.1M | $50.2M |
| Operating income | $30.5M | $24.3M | $6.1M | -$8.2M | -$1.5M | -$58.7M |
| Net income | $23.9M | $18.7M | $5.1M | -$7.5M | -$6.3M | -$57.3M |
| Diluted EPS | $1.19 | $0.92 | $0.25 | -$0.37 | -$0.30 | -$2.74 |
| Operating cash flow | $40.1M | $18.5M | $27.8M | $4.3M | $4.7M | -$28.4M |
| Free cash flow | $37.6M | $16.7M | $22.5M | -$194,000.00 | -$395,000.00 | -$33.0M |
| Gross margin | 27.8% | 28.3% | 30.9% | 30.9% | 30.5% | 28.1% |
| Operating margin | 10.1% | 8.9% | 2.4% | -3.0% | -0.7% | -32.8% |
| Net margin | 7.9% | 6.9% | 2.1% | -2.7% | -2.8% | -32.0% |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $66.2M | $58.0M | $52.0M | $50.8M | $51.2M | $44.4M | $40.7M | $42.8M |
| Gross profit | $19.0M | $18.8M | $16.1M | $15.2M | $14.4M | $12.4M | $9.5M | $13.9M |
| Operating income | $4.4M | $554,000.00 | -$450,000.00 | -$6.0M | -$34.1M | -$8.4M | -$10.5M | -$5.7M |
| Net income | $3.8M | $2.3M | -$707,000.00 | -$11.6M | -$34.2M | -$8.5M | -$10.6M | -$4.1M |
| Diluted EPS | $0.18 | $0.11 | -$0.03 | -$0.56 | -$1.65 | -$0.41 | -$0.50 | -$0.18 |
| Operating cash flow | -$8.5M | $7.4M | -$1.2M | $7.0M | -$12.3M | -$2.2M | -$9.2M | -$4.7M |
| Free cash flow | -$9.2M | $6.1M | -$1.9M | $4.6M | -$13.6M | -$4.8M | -$9.2M | -$5.5M |
| Gross margin | 28.8% | 32.3% | 31.0% | 29.9% | 28.1% | 28.0% | 23.3% | 32.6% |
| Operating margin | 6.6% | 1.0% | -0.9% | -11.9% | -66.7% | -18.9% | -25.7% | -13.3% |
| Net margin | 5.7% | 4.0% | -1.4% | -22.9% | -66.7% | -19.2% | -26.0% | -9.5% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | KRULIK DOUGLAS· CAO and Interim CFO | Award | 32,500 | $0.00 | $0.00 | filing |
| 2026-06-08 | NINA CAPITAL HOLDINGS INC. | Buy | 25,000 | $1.75 | $43,725.00 | filing |
| 2026-01-21 | FULGONI GIAN | D | 26,057 | $0.00 | $0.00 | filing |
| 2025-10-30 | FULGONI GIAN | Award | 33,846 | $0.00 | $0.00 | filing |
| 2025-10-30 | KRULIK DOUGLAS· CAO and Interim CFO | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-10-30 | LaCamp James | Award | 34,866 | $0.00 | $0.00 | filing |
| 2025-10-30 | Mennen Justin L. | Award | 33,846 | $0.00 | $0.00 | filing |
| 2025-10-30 | Solivan Leah | Award | 33,846 | $0.00 | $0.00 | filing |
| 2025-10-30 | Batushansky Peter | Award | 33,846 | $0.00 | $0.00 | filing |
| 2025-09-09 | KRULIK DOUGLAS· Chief Accounting Officer | Award | 10,000 | $0.00 | $0.00 | filing |
| 2025-08-13 | Silvercape Investments Ltd | Buy | 101,000 | $3.17 | $320,170.00 | filing |
| 2025-08-01 | Silvercape Investments Ltd | Buy | 118,200 | $3.21 | $379,422.00 | filing |
| 2025-07-21 | NINA CAPITAL HOLDINGS INC. | Buy | 25,000 | $3.50 | $87,425.00 | filing |
| 2025-07-18 | Silvercape Investments Ltd | Buy | 17,565 | $3.23 | $56,734.95 | filing |
| 2025-07-17 | Silvercape Investments Ltd | Buy | 31,701 | $3.15 | $99,858.15 | filing |
| 2025-07-02 | Silvercape Investments Ltd | Buy | 2,817 | $3.22 | $9,070.74 | filing |
| 2025-07-01 | Silvercape Investments Ltd | Buy | 694 | $3.21 | $2,227.74 | filing |
Latest 17 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.